High levels of pigment epithelium-derived factor in diabetes impair wound healing through suppression of wnt signaling

Diabetes

Volumn 64, Issue 4, 2015, Pages 1407-1419

  Qi, Weiwei ^a,b   Yang, Chuan ^c   Dai, Zhiyu ^a   Che, Di ^a   Feng, Juan ^a   Mao, Yuling ^a   Cheng, Rui ^b   Wang, Zhongxiao ^b   He, Xuemin ^b   Zhou, Ti ^a   Gu, Xiaoqiong ^d   Yan, Li ^c   Yang, Xia ^a,c   Ma, Jian Xing ^b   Gao, Guoquan ^a,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c SUN YAT SEN UNIVERSITY   (China)

^d Guangzhou Women and Children's Medical Center   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM CHLORIDE; PIGMENT EPITHELIUM DERIVED FACTOR; WNT PROTEIN; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; ENDOTHELIAL PROGENITOR CELL; HUMAN; MICROVASCULATURE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; SKINFOLD THICKNESS; WNT SIGNALING PATHWAY; WOUND HEALING IMPAIRMENT; ANIMAL; BLOOD; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; WOUND HEALING;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC FOOT; EYE PROTEINS; HUMANS; MICE; NERVE GROWTH FACTORS; SERPINS; SKIN; WNT SIGNALING PATHWAY; WOUND HEALING;

EID: 84929507287     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1111     Document Type: Article

References (52)

1. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007;117: 1219-1222
2. Shaw JE, Boulton AJ. The pathogenesis of diabetic foot problems: An overview. Diabetes 1997;46(Suppl. 2): S58-S61
3. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9: 653-660
4. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341: 738-746
5. Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999;103: 1231-1236
6. Lombardo MF, Iacopino P, Cuzzola M, et al. Type 2 diabetes mellitus impairs the maturation of endothelial progenitor cells and increases the number of circulating endothelial cells in peripheral blood. Cytometry A 2012;81: 856-864
7. Liu JT, Chen YL, Chen WC, et al. Role of pigment epithelium-derived factor in stem/progenitor cell-associated neovascularization. J Biomed Biotechnol 2012; 2012: 871272
8. Zentilin L, Tafuro S, Zacchigna S, et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006;107: 3546-3554
9. O'Neill TJ 4th, Wamhoff BR, Owens GK, Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 2005;97: 1027-1035
10. Takahashi T, Kalka C, Masuda H, et al. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5: 434-438
11. Gill M, Dias S, Hattori K, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001; 88: 167-174
12. Tong J, Gordon MS, Srour EF, et al. In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. Blood 1993;82: 784-791
13. Heissig B, Werb Z, Rafii S, Hattori K. Role of c-kit/Kit ligand signaling in regulating vasculogenesis. Thromb Haemost 2003;90: 570-576
14. Gallagher KA, Liu ZJ, Xiao M, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007;117: 1249-1259
15. Aicher A, Heeschen C, Mildner-Rihm C, et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003; 9: 1370-1376
16. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis. Science 1999;285: 245-248
17. Crowe S, Wu LE, Economou C, et al. Pigment epithelium-derived factor contributes to insulin resistance in obesity. Cell Metab 2009;10: 40-47
18. Dai Z, Qi W, Li C, et al. Dual regulation of adipose triglyceride lipase by pigment epithelium-derived factor: A novel mechanistic insight into progressive obesity. Mol Cell Endocrinol 2013;377: 123-134
19. Becerra SP, Notario V. The effects of PEDF on cancer biology: Mechanisms of action and therapeutic potential. Nat Rev Cancer 2013;13: 258-271
20. Gao G, Li Y, Fant J, Crosson CE, Becerra SP, Ma JX. Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in brown Norway and Sprague Dawley rats contributing to different susceptibilities to retinal neovascularization. Diabetes 2002;51: 1218-1225
21. Jenkins A, Zhang SX, Gosmanova A, et al. Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes Res Clin Pract 2008;82: E5-e7
22. Jenkins AJ, Zhang SX, Rowley KG, et al. Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in type 1 diabetes. Diabet Med 2007;24: 1345-1351
23. Ho TC, Chen SL, Wu JY, et al. PEDF promotes self-renewal of limbal stem cell and accelerates corneal epithelial wound healing. Stem Cells 2013;31: 1775-1784
24. Park K, Lee K, Zhang B, et al. Identification of a novel inhibitor of the canonical Wnt pathway. Mol Cell Biol 2011;31: 3038-3051
25. Fathke C, Wilson L, Shah K, et al. Wnt signaling induces epithelial differentiation during cutaneous wound healing. BMC Cell Biol 2006;7: 4
26. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell 2009;17: 9-26
27. George SJ. Wnt pathway: A new role in regulation of inflammation. Arterioscler Thromb Vasc Biol 2008;28: 400-402
28. Masckauchán TN, Kitajewski J. Wnt/Frizzled signaling in the vasculature: New angiogenic factors in sight. Physiology (Bethesda) 2006;21: 181-188
29. Barcelos LS, Duplaa C, Kränkel N, et al. Human CD133+ progenitor cells promote the healing of diabetic ischemic ulcers by paracrine stimulation of angiogenesis and activation of Wnt signaling. Circ Res 2009;104: 1095-1102
30. Chen J, Stahl A, Krah NM, et al. Wnt signaling mediates pathological vascular growth in proliferative retinopathy. Circulation 2011;124: 1871-1881
31. Dejana E. The role of wnt signaling in physiological and pathological angiogenesis. Circ Res 2010;107: 943-952
32. Zhang B, Ma JX. Wnt pathway antagonists and angiogenesis. Protein Cell 2010;1: 898-906
33. Liu X, McBride J, Zhou Y, Liu Z, Ma JX. Regulation of endothelial progenitor cell release by Wnt signaling in bone marrow. Invest Ophthalmol Vis Sci 2013;54: 7386-7394
34. McBride JD, Jenkins AJ, Liu X, et al. Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signaling. J Invest Dermatol 2014; 134: 1725-1734
35. Wang JJ, Zhang SX, Mott R, et al. Salutary effect of pigment epitheliumderived factor in diabetic nephropathy: Evidence for antifibrogenic activities. Diabetes 2006;55: 1678-1685
36. Marrotte EJ, Chen DD, Hakim JS, Chen AF. Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. J Clin Invest 2010;120: 4207-4219
37. Zhang B, Zhou KK, Ma JX. Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/betacatenin pathway. Diabetes 2010;59: 1809-1816
38. Xu G, Cheng L, Wen W, et al. Inverse association between T-cell immunoglobulin and mucin domain-1 and T-bet in a mouse model of allergic rhinitis. Laryngoscope 2007;117: 960-964
39. Yang H, Cheng R, Liu G, et al. PEDF inhibits growth of retinoblastoma by anti-angiogenic activity. Cancer Sci 2009;100: 2419-2425
40. Duda DG, Fukumura D, Jain RK. Role of eNOS in neovascularization: NO for endothelial progenitor cells. Trends Mol Med 2004;10: 143-145
41. Tombran-Tink J, Barnstable CJ. Therapeutic prospects for PEDF: More than a promising angiogenesis inhibitor. Trends Mol Med 2003;9: 244-250
42. Seth P, Kumari R, Madhavan S, et al. Prevention of renal ischemiareperfusion-induced injury in rats by picroliv. Biochem Pharmacol 2000;59: 1315-1322
43. Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX. Pigment epitheliumderived factor (PEDF) is an endogenous antiinflammatory factor. FASEB J 2006; 20: 323-325
44. Wang JJ, Zhang SX, Lu K, et al. Decreased expression of pigment epithelium-derived factor is involved in the pathogenesis of diabetic nephropathy. Diabetes 2005;54: 243-250
45. Matsuyama K, Ogata N, Matsuoka M, et al. Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy. Mol Vis 2008;14: 992-996
46. Monteiro-Soares M, Boyko EJ, Ribeiro J, Ribeiro I, Dinis-Ribeiro M. Predictive factors for diabetic foot ulceration: A systematic review. Diabetes Metab Res Rev 2012;28: 574-600
47. Hoyt RE. Peripheral arterial disease in people with diabetes: Response to consensus statement. Diabetes Care 2004;27: 2095
48. Petrofsky JS, McLellan K, Bains GS, et al. Skin heat dissipation: The influence of diabetes, skin thickness, and subcutaneous fat thickness. Diabetes Technol Ther 2008;10: 487-493
49. Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999;85: 221-228
50. Guo S, Arai K, Stins MF, Chuang DM, Lo EH. Lithium upregulates vascular endothelial growth factor in brain endothelial cells and astrocytes. Stroke 2009; 40: 652-655
51. Kaga S, Zhan L, Altaf E, Maulik N. Glycogen synthase kinase-3beta/betacatenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol 2006;40: 138-147
52. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858-864